vs

Side-by-side financial comparison of J.Jill, Inc. (JILL) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $150.5M, roughly 1.3× J.Jill, Inc.). REPLIGEN CORP runs the higher net margin — 6.7% vs 6.1%, a 0.6% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -0.5%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $16.0M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 0.1%).

J.Jill is an American womenswear retailer founded in 1955 in Massachusetts. It has been a publicly traded company since 2017. J.Jill is headquartered in Quincy, Massachusetts.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

JILL vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$150.5M
JILL
Growing faster (revenue YoY)
RGEN
RGEN
+14.1% gap
RGEN
13.6%
-0.5%
JILL
Higher net margin
RGEN
RGEN
0.6% more per $
RGEN
6.7%
6.1%
JILL
More free cash flow
RGEN
RGEN
$1.5M more FCF
RGEN
$17.6M
$16.0M
JILL
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
0.1%
JILL

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
JILL
JILL
RGEN
RGEN
Revenue
$150.5M
$197.9M
Net Profit
$9.2M
$13.3M
Gross Margin
70.9%
52.5%
Operating Margin
9.9%
9.0%
Net Margin
6.1%
6.7%
Revenue YoY
-0.5%
13.6%
Net Profit YoY
-25.5%
143.9%
EPS (diluted)
$0.60
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JILL
JILL
RGEN
RGEN
Q4 25
$150.5M
$197.9M
Q3 25
$154.0M
$188.8M
Q2 25
$153.6M
$182.4M
Q1 25
$142.8M
$169.2M
Q4 24
$151.3M
$174.1M
Q3 24
$155.2M
$154.9M
Q2 24
$161.5M
$154.1M
Q1 24
$150.3M
$151.3M
Net Profit
JILL
JILL
RGEN
RGEN
Q4 25
$9.2M
$13.3M
Q3 25
$10.5M
$14.9M
Q2 25
$11.7M
$14.9M
Q1 25
$2.2M
$5.8M
Q4 24
$12.3M
$-30.3M
Q3 24
$8.2M
$-654.0K
Q2 24
$16.7M
$3.3M
Q1 24
$4.8M
$2.1M
Gross Margin
JILL
JILL
RGEN
RGEN
Q4 25
70.9%
52.5%
Q3 25
68.4%
53.2%
Q2 25
71.8%
50.0%
Q1 25
66.3%
53.6%
Q4 24
71.4%
26.1%
Q3 24
70.5%
50.0%
Q2 24
72.9%
49.8%
Q1 24
67.5%
49.5%
Operating Margin
JILL
JILL
RGEN
RGEN
Q4 25
9.9%
9.0%
Q3 25
10.9%
8.9%
Q2 25
12.4%
7.6%
Q1 25
3.6%
3.9%
Q4 24
12.7%
-17.7%
Q3 24
14.8%
-5.1%
Q2 24
17.6%
1.0%
Q1 24
7.0%
1.3%
Net Margin
JILL
JILL
RGEN
RGEN
Q4 25
6.1%
6.7%
Q3 25
6.8%
7.9%
Q2 25
7.6%
8.2%
Q1 25
1.6%
3.4%
Q4 24
8.2%
-17.4%
Q3 24
5.3%
-0.4%
Q2 24
10.3%
2.2%
Q1 24
3.2%
1.4%
EPS (diluted)
JILL
JILL
RGEN
RGEN
Q4 25
$0.60
$0.24
Q3 25
$0.69
$0.26
Q2 25
$0.76
$0.26
Q1 25
$0.11
$0.10
Q4 24
$0.80
$-0.55
Q3 24
$0.54
$-0.01
Q2 24
$1.16
$0.06
Q1 24
$0.33
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JILL
JILL
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$58.0M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$129.0M
$2.1B
Total Assets
$458.0M
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JILL
JILL
RGEN
RGEN
Q4 25
$58.0M
$767.6M
Q3 25
$45.5M
$748.7M
Q2 25
$31.2M
$708.9M
Q1 25
$35.4M
$697.2M
Q4 24
$38.8M
$757.4M
Q3 24
$28.5M
$784.0M
Q2 24
$77.1M
$809.1M
Q1 24
$62.2M
$780.6M
Total Debt
JILL
JILL
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
JILL
JILL
RGEN
RGEN
Q4 25
$129.0M
$2.1B
Q3 25
$121.5M
$2.1B
Q2 25
$112.0M
$2.1B
Q1 25
$105.8M
$2.0B
Q4 24
$103.3M
$2.0B
Q3 24
$90.4M
$2.0B
Q2 24
$53.1M
$2.0B
Q1 24
$37.2M
$2.0B
Total Assets
JILL
JILL
RGEN
RGEN
Q4 25
$458.0M
$2.9B
Q3 25
$436.5M
$2.9B
Q2 25
$432.9M
$2.9B
Q1 25
$417.7M
$2.9B
Q4 24
$418.3M
$2.8B
Q3 24
$390.8M
$2.8B
Q2 24
$443.9M
$2.9B
Q1 24
$428.2M
$2.8B
Debt / Equity
JILL
JILL
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JILL
JILL
RGEN
RGEN
Operating Cash FlowLast quarter
$19.1M
$25.7M
Free Cash FlowOCF − Capex
$16.0M
$17.6M
FCF MarginFCF / Revenue
10.6%
8.9%
Capex IntensityCapex / Revenue
2.0%
4.1%
Cash ConversionOCF / Net Profit
2.07×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$37.6M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JILL
JILL
RGEN
RGEN
Q4 25
$19.1M
$25.7M
Q3 25
$19.4M
$48.1M
Q2 25
$5.3M
$28.6M
Q1 25
$8.1M
$15.0M
Q4 24
$19.1M
$39.2M
Q3 24
$16.4M
$49.3M
Q2 24
$21.5M
$42.2M
Q1 24
$6.6M
$44.7M
Free Cash Flow
JILL
JILL
RGEN
RGEN
Q4 25
$16.0M
$17.6M
Q3 25
$17.1M
$43.4M
Q2 25
$3.1M
$21.5M
Q1 25
$1.4M
$11.4M
Q4 24
$14.6M
$33.6M
Q3 24
$15.0M
$42.3M
Q2 24
$19.8M
$37.4M
Q1 24
$1.8M
$36.4M
FCF Margin
JILL
JILL
RGEN
RGEN
Q4 25
10.6%
8.9%
Q3 25
11.1%
23.0%
Q2 25
2.0%
11.8%
Q1 25
1.0%
6.8%
Q4 24
9.7%
19.3%
Q3 24
9.6%
27.3%
Q2 24
12.2%
24.3%
Q1 24
1.2%
24.0%
Capex Intensity
JILL
JILL
RGEN
RGEN
Q4 25
2.0%
4.1%
Q3 25
1.5%
2.5%
Q2 25
1.5%
3.9%
Q1 25
4.7%
2.1%
Q4 24
2.9%
3.2%
Q3 24
0.9%
4.5%
Q2 24
1.1%
3.1%
Q1 24
3.2%
5.5%
Cash Conversion
JILL
JILL
RGEN
RGEN
Q4 25
2.07×
1.93×
Q3 25
1.84×
3.23×
Q2 25
0.46×
1.92×
Q1 25
3.60×
2.57×
Q4 24
1.54×
Q3 24
2.00×
Q2 24
1.29×
12.70×
Q1 24
1.39×
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

JILL
JILL

Sales Channel Through Intermediary$80.1M53%
Sales Channel Directly To Consumer$70.5M47%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons